European Archives - Page 441 of 1207 - European Medical Journal

Clinical Presentation and Diagnostic Features of Onychomatricoma: A Case Report

Onychomatricoma is an infrequent, benign fibroepithelial tumour originating from the nail matrix. While the exact cause of onychomatricoma…

Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity

Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…

Scarring Alopecia: Cutting-Edge Approaches

Jerry Shapiro, New York University (NYU) Langone Health, USA, presented on evaluating and diagnosing scarring alopecia…

Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo

Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…

Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm

Lichen sclerosus (LS) is a chronic inflammatory condition primarily affecting the genital area, characterised by hypopigmented skin…

A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study

Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…

The Safety Profile of Biological Agents in Patients with Psoriasis and HIV: A Systematic Review

Patients with HIV and severe psoriasis who require biological agents are thus thought to be at increased risk of adverse events….

Live Webinar: ECLS with Xenios console | December 12th 7:30 AM - 8:30 AM CET

Join us to get to know Fresenius Medical Care’s ECMO offering – a dedicated technology combining both, heart and lung support in one single platform.

Neurofilament Light Chain Levels Predict Multiple Sclerosis Disability Progression

According to new research, elevation of serum neurofilament light chain, a biomarker of neuroaxonal injury, can predict disability worsening in multiple sclerosis within 1–2 years.

Does Herpes Simplex Virus 1 Increase Risk of Alzheimer’s Disease?

New evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease, according to a systematic review of published studies.